Security key
05156V102
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)
CUSIP: 05156V102
Q1 2020 13F Holders as of 31 Mar 2020
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 132,929,348
- Total 13F shares
- 60,307,130
- Share change
- +11,811,452
- Total reported value
- $875,021,915
- Put/Call ratio
- 92%
- Price per share
- $14.51
- Number of holders
- 122
- Value change
- +$158,173,274
- Number of buys
- 68
- Number of sells
- 46
Report period
Q1 2020
Institutions
122
Top holders
10
AUPH full security history
Newer quarter: Q2 2020
Previous quarter: Q4 2019
Aurinia Pharmaceuticals Inc. SEC filings
Aurinia Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05156V102
Recent filing periods:
Top shareholders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
6%
|
8,030,058
|
$162,689,000 | — | 31 Dec 2019 | |
| Consonance Capital Management LP |
13F
|
Company |
5%
|
6,625,671
|
$134,236,000 | — | 31 Dec 2019 | |
| NEA Management Company, LLC |
13F
|
Company |
3.9%
|
5,172,683
|
$104,799,000 | — | 31 Dec 2019 | |
| HealthCor Management, L.P. |
13F
|
Company |
3.6%
|
4,820,330
|
$97,660,000 | — | 31 Dec 2019 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2.7%
|
3,595,633
|
$72,848,000 | — | 31 Dec 2019 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.8%
|
2,345,447
|
$47,519,000 | — | 31 Dec 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.5%
|
1,945,094
|
$39,408,000 | — | 31 Dec 2019 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.3%
|
1,701,929
|
$34,481,000 | — | 31 Dec 2019 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1%
|
1,328,000
|
$26,905,000 | — | 31 Dec 2019 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.8%
|
1,057,500
|
$21,425,000 | — | 31 Dec 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.71%
|
937,491
|
$18,993,000 | — | 31 Dec 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.65%
|
869,311
|
$17,612,000 | — | 31 Dec 2019 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.65%
|
861,870
|
$17,461,000 | — | 31 Dec 2019 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.54%
|
716,666
|
$14,520,000 | — | 31 Dec 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.47%
|
622,804
|
$12,618,000 | — | 31 Dec 2019 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.45%
|
600,000
|
$12,156,000 | — | 31 Dec 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.44%
|
578,534
|
$11,721,000 | — | 31 Dec 2019 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.36%
|
481,104
|
$9,747,000 | — | 31 Dec 2019 | |
| Broadfin Capital, LLC |
13F
|
Company |
0.3%
|
400,000
|
$8,104,000 | — | 31 Dec 2019 | |
| Crawford Lake Capital Management, LLC |
13F
|
Company |
0.27%
|
358,082
|
$7,255,000 | — | 31 Dec 2019 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.26%
|
350,000
|
$7,091,000 | — | 31 Dec 2019 | |
| Atom Investors LP |
13F
|
Company |
0.26%
|
343,651
|
$6,962,000 | — | 31 Dec 2019 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.23%
|
312,268
|
$6,327,000 | — | 31 Dec 2019 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.2%
|
272,298
|
$5,517,000 | — | 31 Dec 2019 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.2%
|
267,050
|
$5,410,000 | — | 31 Dec 2019 | |
| Creative Planning |
13F
|
Company |
0.2%
|
265,700
|
$5,383,000 | — | 31 Dec 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.18%
|
245,280
|
$4,970,000 | — | 31 Dec 2019 | |
| Avidity Partners Management LP |
13F
|
Company |
0.17%
|
232,000
|
$4,700,000 | — | 31 Dec 2019 | |
| Maven Securities LTD |
13F
|
Company |
0.16%
|
214,673
|
$4,371,000 | — | 31 Dec 2019 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.16%
|
215,440
|
$4,368,000 | — | 31 Dec 2019 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.13%
|
170,723
|
$3,459,000 | — | 31 Dec 2019 | |
| Global IMC LLC |
13F
|
Company |
0.12%
|
159,984
|
$3,241,000 | — | 31 Dec 2019 | |
| IRONWOOD INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.12%
|
152,989
|
$3,100,000 | — | 31 Dec 2019 | |
| J. Goldman & Co LP |
13F
|
Company |
0.11%
|
152,518
|
$3,090,000 | — | 31 Dec 2019 | |
| Swiss National Bank |
13F
|
Company |
0.11%
|
152,500
|
$3,084,000 | — | 31 Dec 2019 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.11%
|
146,841
|
$2,975,000 | — | 31 Dec 2019 | |
| Pinz Capital Management, LP |
13F
|
Company |
0.1%
|
136,200
|
$2,759,000 | — | 31 Dec 2019 | |
| Burrage Capital Management LLC |
13F
|
Company |
0.1%
|
126,533
|
$2,564,000 | — | 31 Dec 2019 | |
| BARCLAYS PLC |
13F
|
Company |
0.08%
|
104,375
|
$2,115,000 | — | 31 Dec 2019 | |
| Granite Point Capital Management, L.P. |
13F
|
Company |
0.08%
|
100,000
|
$2,026,000 | — | 31 Dec 2019 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.08%
|
100,000
|
$2,026,000 | — | 31 Dec 2019 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.07%
|
93,085
|
$1,886,000 | — | 31 Dec 2019 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.07%
|
90,788
|
$1,839,000 | — | 31 Dec 2019 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
85,928
|
$1,741,000 | — | 31 Dec 2019 | |
| UBS Group AG |
13F
|
Company |
0.06%
|
82,960
|
$1,681,000 | — | 31 Dec 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.06%
|
79,993
|
$1,620,000 | — | 31 Dec 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
76,562
|
$1,550,000 | — | 31 Dec 2019 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.05%
|
66,000
|
$1,413,720 | — | 31 Dec 2019 | |
| Walleye Capital LLC |
13F
|
Company |
0.05%
|
68,570
|
$1,389,000 | — | 31 Dec 2019 | |
| Trexquant Investment LP |
13F
|
Company |
0.05%
|
66,304
|
$1,343,000 | — | 31 Dec 2019 |
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q1 2020
As of 31 Mar 2020,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
122 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,307,130 shares.
The largest 10 holders included
HealthCor Management, L.P., FMR LLC, Consonance Capital Management LP, NEA Management Company, LLC, Point72 Asset Management, L.P., Avoro Capital Advisors LLC, BAKER BROS. ADVISORS LP, PICTET ASSET MANAGEMENT LTD, RENAISSANCE TECHNOLOGIES LLC, and ORBIMED ADVISORS LLC.
This page lists
122
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2020 vs Q4 2019 Across Filers
Q4 2019 holders
110
Q1 2020 holders
122
Holder diff
12
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 Value $ | Q1 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.